IRLAB Therapeutics AB (publ)

OM:IRLAB A Stock Report

Market Cap: SEK 793.6m

IRLAB Therapeutics Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Kristina Torfgard

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenure12.1yrs
Board average tenure2.8yrs

Recent management updates

Recent updates

Is IRLAB Therapeutics (STO:IRLAB A) Using Debt Sensibly?

Oct 30
Is IRLAB Therapeutics (STO:IRLAB A) Using Debt Sensibly?

IRLAB Therapeutics (STO:IRLAB A) Has Debt But No Earnings; Should You Worry?

Jun 06
IRLAB Therapeutics (STO:IRLAB A) Has Debt But No Earnings; Should You Worry?

Here's Why We're Watching IRLAB Therapeutics' (STO:IRLAB A) Cash Burn Situation

Jan 04
Here's Why We're Watching IRLAB Therapeutics' (STO:IRLAB A) Cash Burn Situation

Here's Why IRLAB Therapeutics (STO:IRLAB A) Must Use Its Cash Wisely

Sep 21
Here's Why IRLAB Therapeutics (STO:IRLAB A) Must Use Its Cash Wisely

We Think IRLAB Therapeutics (STO:IRLAB A) Needs To Drive Business Growth Carefully

Mar 18
We Think IRLAB Therapeutics (STO:IRLAB A) Needs To Drive Business Growth Carefully

IRLAB Therapeutics (STO:IRLAB A) Is In A Good Position To Deliver On Growth Plans

Dec 01
IRLAB Therapeutics (STO:IRLAB A) Is In A Good Position To Deliver On Growth Plans

We Like IRLAB Therapeutics' (STO:IRLAB A) Earnings For More Than Just Statutory Profit

May 19
We Like IRLAB Therapeutics' (STO:IRLAB A) Earnings For More Than Just Statutory Profit

We're Interested To See How IRLAB Therapeutics (STO:IRLAB A) Uses Its Cash Hoard To Grow

Sep 11
We're Interested To See How IRLAB Therapeutics (STO:IRLAB A) Uses Its Cash Hoard To Grow

We're Interested To See How IRLAB Therapeutics (STO:IRLAB A) Uses Its Cash Hoard To Grow

Apr 30
We're Interested To See How IRLAB Therapeutics (STO:IRLAB A) Uses Its Cash Hoard To Grow

What Is The Ownership Structure Like For IRLAB Therapeutics AB (publ) (STO:IRLAB A)?

Mar 19
What Is The Ownership Structure Like For IRLAB Therapeutics AB (publ) (STO:IRLAB A)?

We Think IRLAB Therapeutics (STO:IRLAB A) Can Afford To Drive Business Growth

Jan 25
We Think IRLAB Therapeutics (STO:IRLAB A) Can Afford To Drive Business Growth

Our View On IRLAB Therapeutics' (STO:IRLAB A) CEO Pay

Dec 21
Our View On IRLAB Therapeutics' (STO:IRLAB A) CEO Pay

What Is The Ownership Structure Like For IRLAB Therapeutics AB (publ) (STO:IRLAB A)?

Nov 25
What Is The Ownership Structure Like For IRLAB Therapeutics AB (publ) (STO:IRLAB A)?

CEO

Kristina Torfgard (61 yo)

less than a year

Tenure

Dr. Kristina Torfgard, Ph.D. is Chief Executive Officer of IRLAB Therapeutics AB (publ) from August 1, 2024. Dr. Torfgard served as Vice President & Global Project Head at Albireo AB. Dr. Torfgard served a...


Leadership Team

NamePositionTenureCompensationOwnership
Kristina Torfgard
Chief Executive Officerless than a yearno datano data
Viktor Siewertz
Chief Financial Officer8.1yrsno data0.46%
SEK 3.7m
Clas Sonesson
Chief Scientific Officer12.1yrsno data1.46%
SEK 11.6m
Peder Svensson
Chief Information Officer and Director of Computational Chemistry & Biology12.1yrsno data0.50%
SEK 4.0m
Tove Bergenholt
Global IR & Communicationsno datano datano data
Cecilia Stenberg
Head of Finance & Human Resource and Director of Accounting & Human Resources12.1yrsno datano data
Nicholas Waters
Executive VP and Head of R&Dno dataSEK 1.70m1.44%
SEK 11.4m
Joakim Tedroff
Chief Medical Officer12.1yrsSEK 5.00k1.22%
SEK 9.7m

12.1yrs

Average Tenure

62yo

Average Age

Experienced Management: IRLAB A's management team is seasoned and experienced (12.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Rein Piir
Independent Director9.1yrsSEK 256.25k0.081%
SEK 641.1k
Carola Lemne
Independent Chairman of the Board7.1yrsSEK 400.00k0.027%
SEK 214.2k
Christer Nordstedt
Director1.7yrsSEK 147.50kno data
Veronica Wallin
Independent Director1.7yrsSEK 160.00kno data
Gunnar Olsson
Director8.1yrsSEK 3.10m0.012%
SEK 91.8k
Catharina Wallich
Independent Director2.8yrsSEK 264.17k0.015%
SEK 122.4k
Daniel Johnsson
Director1.7yrsSEK 175.00k8.71%
SEK 69.2m

2.8yrs

Average Tenure

62yo

Average Age

Experienced Board: IRLAB A's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/03 18:33
End of Day Share Price 2025/02/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

IRLAB Therapeutics AB (publ) is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Gonzalo Artiach CastanonABG Sundal Collier Sponsored
null nullABG Sundal Collier Sponsored